LifeStance Health Group, Inc. Cash Flow Statement
LFST / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 7 fiscal years. All figures from audited SEC 10-K filings.
LifeStance Health Group, Inc. generated $146M in operating cash flow and $110M in free cash flow in FY2025. Free cash flow margin was 7.7% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income | $9.7M | -$57.4M | -$186.3M | -$215.6M | -$307.2M | -$13.1M | $5.7M |
| Depreciation & Amortization | $41.6M | $40.7M | $37.4M | $28.9M | $15.1M | $4.4M | $3.0M |
| Operating Cash Flow | $146.2M | $107.3M | -$16.9M | $52.8M | $9.4M | -$22.0M | $17.0M |
| Capital Expenditures | $36.1M | $21.6M | $40.5M | $79.3M | $94.5M | $25.3M | $14.3M |
| Free Cash Flow | $110.0M | $85.7M | -$57.4M | -$26.5M | -$85.1M | -$47.2M | $2.7M |
| FCF Margin | 7.7% | 6.9% | -5.4% | -3.1% | -12.7% | -17.8% | 1.3% |